HalophFGD

Chromosome	Start	End	Strand	ID
chr03	28397081	28411341	+	Cgl03G2315

Theoretical pI	Molecular Weight	Instability Index	Aliphatic Index	GRAVY
5.93	251,322.33 Da	44.88	98.00	-0.08

Category	ID	Description	Start	End	Evalue/Score	InterPro ID
Pfam	PF00560	Leucine Rich Repeat	199	218	0.1	IPR001611
Pfam	PF13920	Zinc finger, C3HC4 type (RING finger)	1297	1333	2.0E-8	-
Pfam	PF08263	Leucine rich repeat N-terminal domain	36	74	6.2E-12	IPR013210
Pfam	PF16040	Domain of unknown function (DUF4792)	1061	1124	2.2E-11	IPR032008
Pfam	PF13855	Leucine rich repeat	103	162	8.9E-8	IPR001611
Pfam	PF00067	Cytochrome P450	1816	2245	1.1E-75	IPR001128
Pfam	PF16041	Domain of unknown function (DUF4793)	1129	1230	3.1E-24	IPR032010
Pfam	PF00067	Cytochrome P450	1493	1776	1.5E-67	IPR001128
Pfam	PF00067	Cytochrome P450	1367	1477	7.9E-14	IPR001128
Pfam	PF00069	Protein kinase domain	678	892	7.6E-38	IPR000719
SUPERFAMILY	SSF56112	Protein kinase-like (PK-like)	661	922	6.2E-64	IPR011009
SUPERFAMILY	SSF48264	Cytochrome P450	1799	2256	1.03E-104	IPR036396
SUPERFAMILY	SSF52047	RNI-like	83	411	3.69E-58	-
SUPERFAMILY	SSF52058	L domain-like	350	604	1.12E-59	-
SUPERFAMILY	SSF48264	Cytochrome P450	1366	1791	3.27E-108	IPR036396
Gene3D	G3DSA:1.10.630.10	Cytochrome P450	1794	2256	5.8E-102	IPR036396
Gene3D	G3DSA:3.30.200.20	Phosphorylase Kinase; domain 1	658	755	6.3E-21	-
Gene3D	G3DSA:3.80.10.10	Ribonuclease Inhibitor	314	611	8.2E-88	IPR032675
Gene3D	G3DSA:3.80.10.10	Ribonuclease Inhibitor	33	184	3.2E-48	IPR032675
Gene3D	G3DSA:3.30.40.10	Zinc/RING finger domain, C3HC4 (zinc finger)	1276	1346	6.3E-11	IPR013083
Gene3D	G3DSA:1.10.510.10	Transferase(Phosphotransferase) domain 1	756	966	1.4E-48	-
Gene3D	G3DSA:3.80.10.10	Ribonuclease Inhibitor	185	243	1.4E-12	IPR032675
Gene3D	G3DSA:3.80.10.10	Ribonuclease Inhibitor	244	313	2.3E-10	IPR032675
Gene3D	G3DSA:1.10.630.10	Cytochrome P450	1359	1789	1.2E-108	IPR036396
SMART	SM00369	LRR_typ_2	421	445	84.0	IPR003591
SMART	SM00369	LRR_typ_2	270	294	23.0	IPR003591
SMART	SM00369	LRR_typ_2	373	397	19.0	IPR003591
SMART	SM00369	LRR_typ_2	542	565	200.0	IPR003591
SMART	SM00369	LRR_typ_2	149	173	8.1	IPR003591
SMART	SM00369	LRR_typ_2	197	220	9.1	IPR003591
SMART	SM00365	LRR_sd22_2	542	565	160.0	-
SMART	SM00365	LRR_sd22_2	197	223	40.0	-
SMART	SM00365	LRR_sd22_2	494	523	730.0	-
SMART	SM00365	LRR_sd22_2	566	594	610.0	-
SMART	SM00365	LRR_sd22_2	149	175	200.0	-
SMART	SM00369	LRR_typ_2	566	591	8.5	IPR003591
SMART	SM00220	serkin_6	677	934	3.6E-30	IPR000719
SMART	SM00365	LRR_sd22_2	421	447	470.0	-
SMART	SM00365	LRR_sd22_2	324	350	210.0	-
ProSiteProfiles	PS50011	Protein kinase domain profile.	677	946	34.223373	IPR000719
ProSiteProfiles	PS51450	Leucine-rich repeat profile.	199	220	7.711955	IPR001611
ProSitePatterns	PS00086	Cytochrome P450 cysteine heme-iron ligand signature.	1730	1739	-	IPR017972
ProSitePatterns	PS00107	Protein kinases ATP-binding region signature.	683	703	-	IPR017441
ProSitePatterns	PS00108	Serine/Threonine protein kinases active-site signature.	804	816	-	IPR008271
PRINTS	PR00019	Leucine-rich repeat signature	200	213	4.2E-5	-
PRINTS	PR00019	Leucine-rich repeat signature	373	386	4.2E-5	-
PRINTS	PR00385	P450 superfamily signature	1728	1737	2.0E-8	IPR001128
PRINTS	PR00385	P450 superfamily signature	1599	1616	2.0E-8	IPR001128
PRINTS	PR00385	P450 superfamily signature	1652	1663	2.0E-8	IPR001128
PRINTS	PR00463	E-class P450 group I signature	1608	1634	3.6E-36	IPR002401
PRINTS	PR00463	E-class P450 group I signature	1651	1669	3.6E-36	IPR002401
PRINTS	PR00463	E-class P450 group I signature	1394	1413	3.6E-36	IPR002401
PRINTS	PR00463	E-class P450 group I signature	1588	1605	3.6E-36	IPR002401
PRINTS	PR00463	E-class P450 group I signature	1737	1760	3.6E-36	IPR002401
PRINTS	PR00463	E-class P450 group I signature	1692	1716	3.6E-36	IPR002401
PRINTS	PR00463	E-class P450 group I signature	1727	1737	3.6E-36	IPR002401
MobiDBLite	mobidb-lite	consensus disorder prediction	1270	1290	-	-
Coils	Coil	Coil	1529	1549	-	-

GO:0006468 (protein phosphorylation)

GO:0004497 (monooxygenase activity) GO:0004672 (protein kinase activity) GO:0005506 (iron ion binding) GO:0005515 (protein binding) GO:0005524 (ATP binding) GO:0016705 (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen) GO:0020037 (heme binding)

K00512 (steroid 17alpha-monooxygenase / 17alpha-hydroxyprogesterone deacetylase [EC:1.14.14.19 1.14.14.32])

ko00140 (Steroid hormone biosynthesis) map00140 (Steroid hormone biosynthesis) ko01100 (Metabolic pathways) map01100 (Metabolic pathways)

R02211 (Progesterone + [Reduced NADPH---hemoprotein reductase] + Oxygen <=> 17alpha-Hydroxyprogesterone + [Oxidized NADPH---hemoprotein reductase] + H2O) R03783 (Pregnenolone + [Reduced NADPH---hemoprotein reductase] + Oxygen <=> 17alpha-Hydroxypregnenolone + [Oxidized NADPH---hemoprotein reductase] + H2O) R04852 (21-Deoxycortisol + [Oxidized NADPH---hemoprotein reductase] + H2O <=> 11beta-Hydroxyprogesterone + [Reduced NADPH---hemoprotein reductase] + Oxygen) R04853 (20alpha-Hydroxycholesterol + [Reduced NADPH---hemoprotein reductase] + Oxygen <=> 17alpha,20alpha-Dihydroxycholesterol + [Oxidized NADPH---hemoprotein reductase] + H2O) R08517 (17alpha-Hydroxypregnenolone + [Reduced NADPH---hemoprotein reductase] + Oxygen <=> Dehydroepiandrosterone + Acetate + [Oxidized NADPH---hemoprotein reductase] + H2O) R08518 (17alpha-Hydroxyprogesterone + [Reduced NADPH---hemoprotein reductase] + Oxygen <=> Androstenedione + Acetate + [Oxidized NADPH---hemoprotein reductase] + H2O)